Literature DB >> 3882580

An immunohistological method for estimating cell growth fractions in rapid histopathological diagnosis during surgery.

J Gerdes.   

Abstract

In the past, it has been impossible to carry out immunohistological staining as part of a rapid histopathological diagnosis during surgery because the available methods were too time-consuming. The present report introduces a rapid indirect immunoperoxidase method that requires only 10-12 min. Thus, the immunological characterization of tumour cells may now be applied as an additional parameter for histopathological diagnosis during surgery. In this first attempt, the monoclonal antibody Ki-67, which reacts with a human nuclear antigen present in proliferating cells and absent in quiescent cells, was applied with a new immunostaining method and the results were compared with those obtained by the more time-consuming routine immunohistological method. There was no significant difference between the percentages of Ki-67-positive cells determined with the two methods in normal or neoplastic human tissues. Since knowledge of the growth rate of a malignant tumour may be of prognostic and/or therapeutic value in individual cases, it might be useful to routinely apply this new approach for histopathological diagnosis during surgery.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882580     DOI: 10.1002/ijc.2910350205

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  15 in total

1.  Clinical growth rate of acoustic schwannomas: correlation with the growth fraction as defined by the monoclonal antibody ki-67.

Authors:  T H Lesser; R C Janzer; P Kleihues; U Fisch
Journal:  Skull Base Surg       Date:  1991

2.  Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67.

Authors:  M Deckert; G Reifenberger; W Wechsler
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

3.  Predicting chemosensitivity of tumors.

Authors:  J Mattern; K Wayss; M Volm
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

4.  The monoclonal antibody Ki-67 as a marker for proliferating cells in stereotactic biopsies of brain tumours.

Authors:  C B Ostertag; B Volk; T Shibata; P Burger; P Kleihues
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

5.  Rapid estimation of the proliferating index of brain tumours.

Authors:  A Detta; E Hitchcock
Journal:  J Neurooncol       Date:  1990-06       Impact factor: 4.130

6.  In vitro sensitivity testing of human renal cell carcinoma with cytostatic agents and interferon alpha-2a.

Authors:  W de Riese; E Allhoff; C G Stief; G Lenis; R Schlick; S Liedke; P Anton; U Jonas
Journal:  Urol Res       Date:  1991

7.  In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labeling technique, and of proliferating pool cells by monoclonal antibody Ki-67.

Authors:  T Morimura; K Kitz; H Budka
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

8.  Expression of the proliferation-associated Ki-67 antigen of transferrin receptors and of DNA polymerase alpha in human tumour lines: implications for in vitro chemoresistance.

Authors:  T Licht; K J Bross; H H Fiebig; K Schötta; D P Berger; C Dreher; G W Löhr; F Herrmann
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

9.  The use of the monoclonal antibody Ki-67 in determination of the growth fraction in pediatric brain tumors.

Authors:  T Shibata; P C Burger
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

10.  Specific cytoplasmic alpha-fetoprotein binding protein in MCF-7 human breast cancer cells and primary breast cancer tissue.

Authors:  W Biddle; E J Sarcione
Journal:  Breast Cancer Res Treat       Date:  1987-12       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.